Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.

Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump. Newsweek has contacted OpenAI and the White House for comment via email.

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI agent that can act

Brazil's data protection watchdog has banned Tools for Humanity from offering payment for iris scanning in the country.

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports.

"I genuinely respect your accomplishments and think you are the most inspiring entrepreneur of our time," Altman wrote in an X post to Musk.

The latest spat began after Altman joined Trump, SoftBank CEO Masayoshi Son, and Oracle Chairman Larry Ellison in a White House ceremony on Tuesday to announce the launch of Stargate, a $500 billion venture to advance the United States’ artificial intelligence infrastructure.

Elon Musk threw shade at OpenAI’s Sam Altman on Tuesday after his rival took center stage at the White House to unveil his ambitious $500 billion “Stargate” AI infrastructure project.

It's Musk vs Altman - again. But look away from the griping and sniping and the more interesting developments relate to Microsoft and OpenAI redefining their partnership.

More orders are expected Tuesday amid fallout from his first moves, including his issuing pardons for more than a thousand rioters convicted in connection with the violent Jan. 6 attack on the U.S. Capitol and his effort to end birthright citizenship.

ChatGPT became inaccessible for millions of users worldwide, showing a 'bad gateway error'. OpenAI promptly issued a fix.